Ignite Creation Date:
2024-05-06 @ 6:49 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05795296
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-30
First Post:
2023-03-21
Brief Title:
Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Organization Data
Organization:
RenJi Hospital
Class:
OTHER
Study ID:
HMPL-013-SH-GC-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
RenJi Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Yingchun Xu
Responsible Party Title:
Dr
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
RenJi Hospital
Old Name:
None
Old Organization:
None